Melanoma May No Longer Be a Death Sentence

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Full Show: Bloomberg Businessweek (05/26)
59:30 - Bloomberg Television takes you behind the scenes of our award-winning magazine "Bloomberg Businessweek." Hosts Carol Massar and Oliver Renick talk with the writers who break news on a weekly basis. (Source: Bloomberg)
  • Full Show: Best of Bloomberg Technology (05/26)
  • Brown Brothers' Thin Favors Asia Over Latin America
  • The Sharing Economy's Entrepreneurial Ecosystems